Press Release
News |
Innovations amp up SAS® Drug Development to help clinical trial researchers bring new drugs to market more efficientlySoftware helps users save money, provides a single version of the truth15 June 2010 - SAS® Drug Development has long enabled organisations to focus resources on efficiently developing drugs rather than building complex clinical technology infrastructures. Now, this mature, powerful solution from SAS, the leader in business analytics, features a host of innovations and enhancements that include an integrated workflow system to automate development processes and an improved SAS programming environment designed for seasoned SAS experts. “After working closely with SAS and reviewing early versions, it’s clear that SAS truly listened to its customers and understands the value of partnering with the industry, getting value from users involved daily in clinical development to enhance SAS Drug Development,” said Francois Beckers, Head of Biostatistics & Data Management at GSK Biologicals – Global Clinical R&D. “I am particularly excited about the new authoring and execution environment, built on a revised architecture that will make such a global platform more valuable for data managers and statisticians while keeping the value of a central repository for consumers of the data analysis and reporting.” SAS Drug Development saves users significant amounts of money by creating secure and consistent single-source access to clinical trials data. This central repository decreases the number of data management infrastructure hours dedicated to each project. “As a mature solution, SAS Drug Development has a legion of satisfied users who have helped evolve the product throughout the years,” said Matt Gross, SAS drug development product manager. “Their feedback, along with input from industry and thought leaders, contributed to the delivery of our next-generation offering that’s designed to meet the changing demands our customers face every day.” “SAS Drug Development facilitates our ‘search and development’ business model by easing scientist access to potential licensing partner clinical data,” said Charlie Dougherty, director, research and development IT, Shire. “I can tell our SAS programmers are eager to utilise the significant innovations to the SAS programme development and execution environment.” About enhancements to the SAS Drug Development solution, IDC health insights research director Alan S. Louie said, “Innovation in the new SAS Drug Development release clearly demonstrates SAS’ continued strong commitment to the industry overall and its efforts to provide valuable tools to life sciences companies of all sizes. As a major business growth area worldwide, we believe that these efforts will provide significant benefits to both SAS and its customers today and for the foreseeable future.” How does SAS® Drug Development work? Created for clinical research professionals who manage and analyse clinical trials data, SAS Drug Development enables operational efficiency, scientific consistency and product integrity for biopharmaceutical organisations. SAS Drug Development users gain operational efficiencies for integrating and analysing data from clinical trials. Operational efficiencies allow companies to increase compound throughput and free statisticians to focus on scientific innovation. In addition, the software allows users to collaborate more effectively with vendors, partners and academic institutions to extract maximum knowledge from all data resources. Other SAS® for Life Sciences customers include Alcon, AstraZeneca, Daiichi Sankyo, McKesson and Monsanto. SAS will demonstrate its life sciences products in Booth #1601 during the 46th DIA Annual Meeting in Washington, D.C., 13th – u 16th June, 2010.
SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions delivered within an integrated framework, SAS helps customers at more than 45,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world
The Power to Know®
.
|
Editorial Contacts:
|